Abstract
The beneficial health effects of emotional writing disclosure (ED) on several chronic diseases have been reported. The aim of this pilot study was to investigate the effects of two ED techniques on psoriatic patients treated with ultraviolet B (UVB) therapy. Forty patients were randomly assigned to two different ED treatments (according to Pennebaker [PW], writing about stressful events, to King [KW], writing about major life goals), or to a control group (CG). Disease severity and quality of life (QoL) were assessed at baseline, halfway through and at the end of UVB treatment, and 4 months after ED. Outcome measures were the PASI and SAPASI scores, the Skindex-29, and the GHQ-12, to assess disease severity, health-related QoL and psychological wellbeing, respectively. Increases in SAPASI scores were recorded between end of therapy and the final assessment in KW (p: 0.07) and CG individuals (p:
| Original language | English |
|---|---|
| Pages (from-to) | 599-605 |
| Number of pages | 7 |
| Journal | European Journal of Dermatology |
| Volume | 20 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sep 2010 |
Fingerprint
Keywords
- Emotional writing disclosure
- Phototherapy
- Psoriasis
- Psychological distress
- Quality of life
ASJC Scopus subject areas
- Dermatology
Cite this
Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet B phototherapy. / Paradisi, Andrea; Abeni, Damiano; Finore, Enzo; Di Pietro, Cristina; Sampogna, Francesca; Mazzanti, Cinzia; Pilla, Maria Antonietta; Tabolli, Stefano.
In: European Journal of Dermatology, Vol. 20, No. 5, 09.2010, p. 599-605.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet B phototherapy
AU - Paradisi, Andrea
AU - Abeni, Damiano
AU - Finore, Enzo
AU - Di Pietro, Cristina
AU - Sampogna, Francesca
AU - Mazzanti, Cinzia
AU - Pilla, Maria Antonietta
AU - Tabolli, Stefano
PY - 2010/9
Y1 - 2010/9
N2 - The beneficial health effects of emotional writing disclosure (ED) on several chronic diseases have been reported. The aim of this pilot study was to investigate the effects of two ED techniques on psoriatic patients treated with ultraviolet B (UVB) therapy. Forty patients were randomly assigned to two different ED treatments (according to Pennebaker [PW], writing about stressful events, to King [KW], writing about major life goals), or to a control group (CG). Disease severity and quality of life (QoL) were assessed at baseline, halfway through and at the end of UVB treatment, and 4 months after ED. Outcome measures were the PASI and SAPASI scores, the Skindex-29, and the GHQ-12, to assess disease severity, health-related QoL and psychological wellbeing, respectively. Increases in SAPASI scores were recorded between end of therapy and the final assessment in KW (p: 0.07) and CG individuals (p:
AB - The beneficial health effects of emotional writing disclosure (ED) on several chronic diseases have been reported. The aim of this pilot study was to investigate the effects of two ED techniques on psoriatic patients treated with ultraviolet B (UVB) therapy. Forty patients were randomly assigned to two different ED treatments (according to Pennebaker [PW], writing about stressful events, to King [KW], writing about major life goals), or to a control group (CG). Disease severity and quality of life (QoL) were assessed at baseline, halfway through and at the end of UVB treatment, and 4 months after ED. Outcome measures were the PASI and SAPASI scores, the Skindex-29, and the GHQ-12, to assess disease severity, health-related QoL and psychological wellbeing, respectively. Increases in SAPASI scores were recorded between end of therapy and the final assessment in KW (p: 0.07) and CG individuals (p:
KW - Emotional writing disclosure
KW - Phototherapy
KW - Psoriasis
KW - Psychological distress
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=77956897450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956897450&partnerID=8YFLogxK
U2 - 10.1684/ejd.2010.1018
DO - 10.1684/ejd.2010.1018
M3 - Article
C2 - 20605769
AN - SCOPUS:77956897450
VL - 20
SP - 599
EP - 605
JO - European Journal of Dermatology
JF - European Journal of Dermatology
SN - 1167-1122
IS - 5
ER -